A review published in Oncotarget’s Volume 15 discusses the potential role of mesenchymal stem cells (MSCs) in cancer treatment. MSCs can target tumors and deliver therapeutic agents directly to cancer cells, potentially improving treatment outcomes and reducing side effects. However, challenges exist, as under certain conditions MSCs may unintentionally promote tumor growth. Clinical trials are investigating MSC-based treatments for various cancers with promising results, but also variability in their effects. Personalized MSC therapies tailored to a patient’s specific tumor characteristics and immune system could enhance efficacy and safety. Further research is needed to understand how MSCs interact with cancer cells and their environment. MSCs may become a key component of personalized cancer treatments in the future.
Source link
Exploring the potential of MSCs in cancer therapy
